28. RISKS RELATED TO THIS OFFERING THERE HAS BEEN NO PRIOR PUBLIC MARKET FOR OUR 
STOCK; THE STOCKS OF TECHNOLOGY COMPANIES HAVE EXPERIENCED EXTREME PRICE AND 
VOLUME FLUCTUATIONS; AND OUR STOCK PRICE MAY BE VOLATILE, WHICH COULD ADVERSELY 
AFFECT YOUR INVESTMENT.
Before this offering, there has been no 
public market for our common stock. An active public market for our common stock 
may not develop or be sustained after this offering. The price of the common 
stock in any such market may be higher or lower than the price you pay. If you 
purchase shares of common stock in this offering, you will pay a price that was 
not established in a competitive market. Rather, you will pay the price that we 
negotiated with the representatives of the underwriters. Many factors could 
cause the market price of our common stock to rise and fall, including: - 
variations in our quarterly results; - announcements of technological 
innovations by us or by our competitors; - introductions of new products or new 
pricing policies by us or by our competitors; - acquisitions or strategic 
alliances by us or by our competitors; - recruitment or departure of key 
personnel; - the gain or loss of significant orders; - the gain or loss of 
significant customers; - changes in the estimates of our operating performance 
or changes in recommendations by any securities analysts that elect to follow 
our stock; and - market conditions in our industry, the industries of our 
customers and the economy as a whole. In addition, stocks of technology 
companies have experienced extreme price and volume fluctuations that often have 
been unrelated or disproportionate to these companies' operating performance. 
Public announcements by companies in our industry concerning, among other 
things, their performance, accounting practices or legal problems could cause 
fluctuations in the market for stocks of these and similar companies. These 
fluctuations could lower the market price of our common stock regardless of our 
actual operating performance. In the past, securities class action litigation 
has often been brought against a company following a period of volatility in the 
market price of its securities. We may in the future be the target of similar 
litigation. Securities litigation could result in substantial costs and divert 
management's attention and resources, which could harm our operating results and 
our business.              
            
29. OUR OFFICERS, DIRECTORS AND AFFILIATED ENTITIES OWN A LARGE PERCENTAGE OF OUR 
COMPANY AND COULD SIGNIFICANTLY INFLUENCE THE OUTCOME OF ACTIONS IN WAYS THAT 
COULD ADVERSELY IMPACT OUR STOCK PRICE
We anticipate that our executive 
officers, directors, entities affiliated with them and other 5% or greater 
stockholders will, in total, beneficially own approximately % of our outstanding 
common stock after this offering. These stockholders, acting together, would be 
able to significantly influence all matters requiring approval by our 
stockholders, including the election of directors. Thus, actions might be taken 
even if other stockholders, including those who purchase shares in this 
offering, oppose them. This concentration of ownership might also have the 
effect of delaying or preventing a change of control of our company, which could 
harm our stock price.          
             
          
30. MANAGEMENT WILL HAVE DISCRETION OVER THE USE OF PROCEEDS FROM THIS OFFERING 
AND COULD SPEND OR INVEST THOSE PROCEEDS IN WAYS WITH WHICH YOU MIGHT NOT 
AGREE
We do not have a definitive quantified 
plan with respect to the use of the net proceeds of this offering. Our 
management will have broad discretion with respect to the use of the net 
proceeds from this offering, and you will be relying on the judgment of our 
management regarding the application of these proceeds. Some of the uses we 
currently anticipate include working capital and other general corporate 
purposes, including sales and marketing expenses, research and development 
expenses, general and administrative expenses and capital expenditures. In 
addition, we may use a portion of the net proceeds to acquire or invest in 
complementary businesses, technologies, product lines or products. These 
investments may not yield a favorable return.                
            
          
         
31. SUBSTANTIAL FUTURE SALES OF OUR COMMON STOCK COULD ADVERSELY AFFECT THE 
MARKET PRICE OF OUR COMMON STOCK.
The market price of our common stock 
could decline as a result of sales of a large number of shares of our common 
stock in the market after this offering or the perception that these sales could 
occur. Based on shares outstanding as of June 30, 2000, upon completion of this 
offering, we will have outstanding shares of common stock, or shares if the 
underwriters' over-allotment option is exercised in full. Of these shares, the 
common stock sold in this offering will be freely tradeable except for any 
shares purchased by our "affiliates" as defined in Rule 144 under the Securities 
Act of 1933. All of the 56,526,243 remaining shares of common stock held by our 
existing shareholders will be subject to 180-day lock-up agreements with the 
underwriters or with us. Morgan Stanley & Co. Incorporated, in its sole 
discretion, may release any portion of the securities subject to these lock-up 
agreements. After the 180-day lock-up period, these shares may be sold in the 
public market, subject to prior registration or qualification for an exemption 
from registration, including, in the case of shares held by affiliates, to 
compliance with volume restrictions. After the lock-up period, of these shares 
will be immediately available for sale in the public market without registration 
under Rule 144. The remaining shares held by our existing stockholders will 
become available for sale under Rule 144 at varying times following the end of 
the 180-day lock-up period. Stockholders owning shares are entitled, pursuant to 
contracts providing for registration rights, to require us to register our 
securities owned by them for public sale. In addition, based on options 
outstanding as of June 30, 2000, after this offering, 7,277,040 shares will be 
issuable under outstanding options and warrants, approximately of which will be 
exercisable 180 days after this offering. We intend to file a registration 
statement to register for resale shares issuable upon the exercise of 
outstanding stock options and shares reserved for future issuance under our 
stock option and stock purchase plans.